Schobel Alexander Mark 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 11, 2024
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Award
Common Stock
2024-03-07+82,500→ 1,065,371 total - Award
Non-Qualified Stock Option (right to buy)
2024-03-07+41,250→ 41,250 totalExercise: $5.68Exp: 2034-03-07→ Common Stock (41,250 underlying)
Footnotes (2)
- [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
- [F2]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.